GABAPENTIN
- Product NDC
- 70934-621
- 11-digit product format
- 709340621
- Labeler code
- 70934
- Product ID
- 70934-621_ab6d6a38-2370-739b-e053-2995a90ad02d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- gabapentin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA211314
- Marketing category
- ANDA
- Marketing start
- 2020-03-20
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-621-30 | 70934062130 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-621-30) | 30 capsule | 2020-03-20 | 0000-00-00 | No | No | Current |
| 70934-621-90 | 70934062190 | 90 CAPSULE in 1 BOTTLE, PLASTIC (70934-621-90) | 90 capsule | 2020-04-14 | 0000-00-00 | No | No | Current |